Rallybio

RLYBNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$85.618 M

$16.16 -0.18%

Close of 7 Aug 2026

Revenue

$858.0K

#3512 by revenue

Earnings

-$8.98M

Loss-making

Shares outstanding

5,310,499

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#315Gossamer BioGOSS$87.0M
#316MAIA BiotechnologyMAIA$86.3M
#317RallybioRLYB$85.6M
#318LifevantageLFVN$85.3M
#319Alterity TherapeuticsATHE$80.7M

Where these numbers come from

Share counts and financials for Rallybio are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.